CLS vs SANM: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
CLS is the larger of the two ($25.96B market cap): the incumbent the market prices for continued execution (9.23x forward earnings, beta 1.35). SANM is the smaller challenger ($7.28B), cheaper on forward earnings (7.03x): more room to run, but more to prove. If you believe in growth, CLS fits: analysts expect its revenue to rise 91% next year, against 17% for SANM. If you believe in paying less for profit, SANM fits: it trades at 7.03x forward earnings, against 9.23x for CLS.
CLS vs SANM: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CLS | SANM | What it tells you |
|---|---|---|---|
| Market cap | $25.96B | $7.28B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 9.23 | 7.03 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 19.42 | 20.15 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.35 | 1.72 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 3% of range | 12% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 4.18 | 2.82 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: SANM is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how CLS and SANM affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CLS and SANM share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CLS and SANM exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Celestica (CLS) do?
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. It reports in two segments. Connectivity & Cloud Solutions (CCS) is the larger and faster-growing one, serving data-center and communications customers with networking switches, servers, storage, and increasingly custom AI/ML compute hardware; in Q1 2026 CCS was about ~80% of total revenue and grew roughly ~76% year over year, with hyperscaler customers making up the majority of that segment. Advanced Technology Solutions (ATS) is the diversified segment covering aerospace and defense, industrial, HealthTech, and capital equipment. The company makes money on the volume and complexity of the hardware it manufactures and on higher-value design and joint-design-manufacturing (JDM) work, where margins are structurally better than commodity contract assembly.
What does Sanmina Corporation (SANM) do?
Sanmina Corporation, founded in Silicon Valley in 1980 and headquartered in San Jose, California, is a Fortune 500 global provider of integrated manufacturing solutions, components, and repair, logistics and after-market services. It serves original equipment manufacturers (OEMs) across industrial and energy, medical, defense and aerospace, automotive, communications networks, and cloud and AI infrastructure, running two businesses: Integrated Manufacturing Solutions and Components, Products and Services. It employs roughly 35,000 people and serves customers from around 20 countries.
CLS vs SANM: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- CLS drivers: Hyperscaler-driven CCS growth; AI networking and compute content.
- SANM drivers: AI and cloud infrastructure ramp; AMD partnership and preferred-manufacturer status.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. For SANM, sanmina operates on thin EMS margins (fiscal 2026 gross margin around 9.6%, operating margin around 6.3% and net margin near 2.6%), so small execution errors or pricing pressure can meaningfully affect profits.
CLS or SANM: which should you pick?
If the story you believe is CLS's (Hyperscaler-driven CCS growth), CLS is the more direct way to own it; if it is SANM's (AI and cloud infrastructure ramp), SANM is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CLS and SANM guides.
CLS vs SANM: the full fundamentals
CLS. At about 19 times trailing and 9 times forward earnings as of November 20, 2026, Celestica trades at a fraction of its mid-2026 multiple, because the share price has fallen while earnings estimates kept rising (analysts expect 2027 EPS near $21.77, up about 93%). The 18-analyst mean target of about $456 sits more than twice the $203.78 close, with a consensus of strong buy. That gap shows how much the market doubts the durability of hyperscaler AI spending; the next report is expected around late January 2027.
SANM. Revenue and earnings stepped up sharply after the ZT Systems acquisition closed in late 2025, and Sanmina has beaten EPS estimates in four of the last five reported quarters, including a large beat in fiscal Q4. The trailing GAAP P/E near 20x is inflated by acquisition costs, while the forward multiple near 7x and a price-to-sales ratio near 0.5x sit far below the stock's roughly 15x ten-year average P/E, a reset driven by the share-price fall rather than lower estimates. The four analysts covering the stock carry a mean target near $250; the next report, for the December quarter, is expected around early February 2027.
Headline figures (approximate, November 2026): CLS shows revenue (ttm) ~$18.2B, q3 2026 revenue ~$5.83B (up ~83% YoY), q3 2026 adjusted eps $3.30 vs $2.96 estimate, net income (ttm) ~$1.25B (~6.8% net margin); SANM shows revenue (fy2026, ended oct 3, 2026) ~$14.53B vs ~$8.1B in FY2025, q4 fy2026 revenue ~$3.86B (up ~84% YoY), eps (q4 fy2026) ~$4.43 vs ~$3.27 estimate, margins (fy2026) ~9.6% gross, ~6.3% operating, ~2.6% net (~$378M net income).
The bottom line: CLS vs SANM
CLS and SANM are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CLS and SANM exposure against your real portfolio. It is not an investment adviser.
Wondering how CLS or SANM fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Celestica
Ask Walnut's AI anything about CLS and see how it fits what you own.
FAQ
What is the difference between CLS and SANM?
+
Celestica is a Toronto-based electronics manufacturing services (EMS) and supply-chain company that designs, builds, and tests hardware for other companies. Sanmina Corporation, founded in Silicon Valley in 1980 and headquartered in San Jose, California, is a Fortune 500 global provider of integrated manufacturing solutions, components, and repair, logistics and after-market services. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CLS or SANM the better stock?
+
Neither is universally better. CLS is the larger incumbent; SANM is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CLS or SANM?
+
On forward P/E (as of November 2026), CLS trades at 9.23x and SANM at 7.03x, so SANM is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CLS and SANM?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CLS vs SANM?
+
CLS: Customer concentration is the headline risk: as of Q1 2026 three customers each represented at least 10% of revenue (roughly 35%, 15%, and 15%), and the top ten customers made up about ~78% of revenue, so losing or being de-prioritized by a single hyperscaler would matter a lot. EMS has historically run thin margins, leaving limited cushion if pricing or volumes compress. The business is tied to AI capital spending, which is cyclical and could slow or pause after a heavy buildout phase. And the stock has re-rated to a much higher multiple than its EMS history, so it carries both competition from Jabil, Flex, Foxconn, and ODMs and the risk that high growth expectations are not met. The stock has already shown that sensitivity: it fell from a 52-week high near $474 to about $204 by November 20, 2026, through a summer pullback in AI-capex sentiment and a November sell-off in AI hardware tied to turmoil at Nvidia, even as quarterly results kept beating estimates. Walnut is not an investment adviser; this page describes the company and is not a recommendation. SANM: Sanmina operates on thin EMS margins (fiscal 2026 gross margin around 9.6%, operating margin around 6.3% and net margin near 2.6%), so small execution errors or pricing pressure can meaningfully affect profits. The ZT Systems business creates heavy revenue concentration tied to AI and data-center capital spending, which is cyclical and could slow if hyperscaler or AMD-related demand cools; revenue stepped down from about $4.0 billion in fiscal Q2 to $3.46 billion in Q3 before recovering to $3.86 billion in Q4. Integration of a multi-billion-dollar acquisition carries operational and financial risk, working capital needs pushed fiscal 2026 free cash flow negative, and the AMD relationship makes results partly dependent on one large partner. The stock fell about 28% over the three months to November 20, 2026, including a decline after a quarter that beat EPS estimates by a wide margin, and swung between roughly $118 and $289 over the past year, so sentiment around AI spending moves the shares hard in both directions. Broader risks include supply-chain disruption, customer concentration, and macro cyclicality across its industrial and communications markets.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CLS or SANM; figures are approximate and dated (as of November 2026). Verify current data before investing.